Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Gut Microbiota Modulation With Synbiotics After Acute Coronary Syndrome [NA]
Clinical trial evaluating gut microbiota modulation with synbiotics after acute coronary syndrome; currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management
A completed clinical trial assessing awareness and perceptions of using high-sensitivity C-reactive protein (hsCRP) to identify systemic inf…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia [Phase 3]
Phase 3 clinical trial of olezarsen (ISIS 678354) in participants with hypertriglyceridemia and atherosclerotic cardiovascular disease, or w…
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: NOTIFY (New Observations Taking Information From Yesterday) [NA]
The NOTIFY trial for Atherosclerotic Cardiovascular Disease sponsored by Stanford University has been withdrawn. No additional trial details…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Improving Lipid Optimization Quality and Treatment Options in ASCVD [NA]
An ongoing, invitation-only clinical trial sponsored by Brigham and Women's Hospital focusing on improving lipid management for hypercholest…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
Novartis is conducting a clinical trial evaluating LDL-C changes and adherence to inclisiran in a population including primary hypercholeste…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study
This clinical trial update describes a study evaluating coronary computed tomography angiography in patients with rheumatoid arthritis and a…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Tailored, Optimised, and Person-centred Programme to Promote Lifestyle Modification in People With Metabolic Syndrome [NA]
A clinical trial to develop a tailored, optimized, and person-centred lifestyle modification program for people with metabolic syndrome to r…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia [Phase 4]
A Phase 4 clinical trial sponsored by Novartis is evaluating a targeted lipid optimization program to improve LDL-C control in adults at ris…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World
A completed master protocol study evaluating the effects of semaglutide on cardiovascular and obesity-related outcomes in real-world adults …
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles. [NA]
A University of Seville-sponsored clinical trial is investigating whether moderate wine consumption affects healthy aging via postprandial e…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease [NA]
This clinical trial update describes the implementation of an algorithm- and multi-professional team-supported strategy to improve lipid man…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease [Phase 3]
This clinical trial update indicates that a Phase 3 study evaluating a polypill together with colchicine for reducing risk of atheroscleroti…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Step-Aerobics Versus Core Exercise for Non-HDL Cholesterol Reduction in Sedentary Women [NA]
A completed trial compared step-aerobics versus core exercise for reducing non-HDL cholesterol in sedentary women.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management [NA]
This entry reports on a randomized controlled trial evaluating alert-based computerized decision support to optimize low-density lipoprotein…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event [Phase 3]
Phase III clinical trial update for AZD0780 evaluating its effect on LDL cholesterol in patients with atherosclerotic cardiovascular disease…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease. [Phase 4]
Phase 4 trial comparing LDL-cholesterol lowering with Inclisiran versus Bempedoic acid in patients with atherosclerotic cardiovascular disea…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Digital Remote Management for Care and Continuous Optimization Versus Usual Care to Reduce Risk of Atherosclerotic Cardiovascular Diseases (DigiCare-ASCVD) [NA]
This document outlines the DigiCare-ASCVD clinical trial evaluating digital remote management for care and continuous optimization versus us…
-
FDA label_change · 2026-01-09FDA Approved: NEXLETOL — Supplemental Application (Esperion Therapeutics, Inc.)
The FDA approved a supplemental application for Nexletol (bempedoic acid) from Esperion Therapeutics, Inc., expanding the drug's labeling.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: HEARTS in Sync + CardioWatch 287-2 [NA]
This trial update indicates a NOT_YET_RECRUITING study integrating HEARTS in Sync with CardioWatch 287-2, evaluating a wearable device for c…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM) [Phase 4]
This Phase 4 trial (PROVE-DM) compares low-intensity statin plus ezetimibe versus high-intensity statin therapy to assess the risk of new-on…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Comparative Study Between Antihyperlipidemic Agents in Treatment of Cardiovascular Diseases [Phase 2, Phase 3]
This document reports the completion of a Phase 2/3 comparative trial of antihyperlipidemic agents for cardiovascular diseases. The sponsor …
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
The CAT-RA study is an observational research trial evaluating coronary artery calcium and troponin biomarkers in patients with rheumatoid a…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus [Phase 4]
Phase 4 clinical trial update evaluating berberine for prevention of cardiovascular disease and diabetes mellitus; the study is currently ac…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C) [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of Inclisiran in Asian participants with atherosclerotic cardiovascular dis…